EYE vs MRNA · rev $1.04B vs rev $145.0M
National Vision Holdings Inc (EYE) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
National Vision Holdings Inc (EYE) is a specialty retail company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported EYE revenue for 2026-07-04 was $1.04B. Net income was $43.6M. Revenue was up 91.7% from 2026-04-04 to 2026-07-04. EYE currently screens at market cap $1.93B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
EYE currently screens at market cap $1.93B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the EYE and MRNA stock pages for the full models.
Not investment advice.